EverHint – SMA 20/50 Crossover – Top 6 Buy and Top 5 Sell Signals for Aug 11, 2026
Excerpt: 11 signals (from 23 total). Healthcare leads (7). price range $14-$538.
What This Signal Is
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
Market Context
Equity markets are experiencing a mild pullback across all major indices, with the Nasdaq leading declines at -0.61% — a typical pattern when growth and technology-sensitive names face modest selling pressure. Despite the day's negative tone, the broader drawdown remains contained, suggesting this is a routine consolidation rather than a directional breakdown. For moving average crossover strategies like SMA20/SMA50, this kind of measured softness can actually be constructive, as it helps distinguish genuine trend signals from noise-driven false breakouts.
Volatility, as measured by the VIX at 15.33, remains in a historically subdued range and is itself declining slightly on the day. Low volatility environments tend to reduce intraday whipsawing, which benefits trend-following crossover signals by allowing price action to develop more cleanly around key moving average levels. However, traders should remain attentive to the possibility that compressed volatility can precede sudden expansion, particularly when indices are in a mild corrective phase.
The dominance of Healthcare among today's signals points to meaningful sector rotation away from more cyclical or growth-oriented areas, which aligns with the relative underperformance of the Nasdaq versus the Dow. Healthcare's defensive characteristics tend to attract capital when risk appetite softens, and SMA crossover signals in this sector may carry higher conviction in the current environment — as defensive sectors often exhibit smoother, more sustained trends that crossover strategies are well-suited to capture.
🟢 Buy Signals (6 of 6 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | BDC | Belden Inc. | Technology | $134.64 | $5.3B |
| 2 | BHP | BHP Group Limited | Basic Materials | $90.02 | $228.7B |
| 3 | EL | The Estée Lauder Comp... | Consumer Defensive | $87.78 | $31.7B |
| 4 | ERO | Ero Copper Corp. | Basic Materials | $36.30 | $3.8B |
| 5 | REPL | Replimune Group, Inc. | Healthcare | $13.65 | $1.1B |
| 6 | VSEC | VSE Corporation | Industrials | $241.82 | $6.8B |
🔴 Sell Signals (5 of 17 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | AFRM | Affirm Holdings, Inc. | Technology | $76.70 | $25.7B |
| 2 | CRS | Carpenter Technology C... | Industrials | $537.57 | $26.7B |
| 3 | EXC | Exelon Corporation | Utilities | $44.87 | $46.2B |
| 4 | GLUE | Monte Rosa Therapeutic... | Healthcare | $15.76 | $1.3B |
| 5 | GOLF | Acushnet Holdings Corp. | Consumer Cyclical | $90.37 | $5.3B |
Field Notes
Sector concentration: Healthcare (7), Industrials (4), Technology (2)
Data coverage: 0.0% insider (7d), 0.0% congressional (30d), 0.0% earnings, 17.4% news (7d)
Peer Analysis
CRS (Carpenter Technology Corporation): Leads 5 peers: ATI ($230.08), TRU ($80.37), WWD ($356.58), ULS ($77.05), LUV ($45.52)
GOLF (Acushnet Holdings Corp.): Leads 5 peers: LTH ($43.81), CROX ($131.71), CVCO ($594.18), FTDR ($83.58), CHH ($102.63)
EXC (Exelon Corporation): Leads 5 peers: DUK ($123.19), D ($68.11), SO ($91.92), ED ($107.50), ETR ($106.57)
Recent Headlines
BDC (Belden Inc.)
- Kayne Anderson BDC Q2 Earnings Call Highlights
- Crescent Capital BDC Q2 Earnings Call Highlights
- Kayne Anderson BDC, Inc. Announces June 30, 2026 Financial Results and Declares Third Quarter 2026 Dividend of $0.40 Per Share
- Belden (BDC) Upgraded to Strong Buy: Here's What You Should Know
CRS (Carpenter Technology Corporation)
- Top 3D Printing Stocks to Buy for Strong Long-Term Potential
REPL (Replimune Group, Inc.)
- REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law
- Deadline Alert: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
- Deadline Soon: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
- Deadline Approaching: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
VSEC (VSE Corporation)
- VSE Q2 Earnings Call Highlights
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (7 signals) suggests sector-specific rotation.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.